Earnings (Loss) Per Common Share

12 Months Ended

Dec. 31, 2021

The following table sets forth the computation of basic and diluted earnings per share available for common stockholders (in thousands, except per share data):


	For the Year Ended December 31,
	2021		2020		2019
Loss from continuing operations	$	(30,284)	$	(328,172)	$	(307,193)
Income (loss) from discontinued operations, net of tax	(7,317)		(6,074)		1,613
Net loss	(37,601)		(334,246)		(305,580)
Less:
Net loss attributable to non-controlling interests	—		—		(3,609)
Net loss available for common shareholders - basic and diluted	$	(37,601)	$	(334,246)	$	(301,971)

Weighted-average common shares outstanding - basic and diluted	86,067		84,928		82,364

Income (loss) per common share
Basic and diluted
Continuing operations	$	(0.35)	$	(3.86)	$	(3.73)
Discontinued operations	(0.09)		(0.08)		0.02
Non-controlling interests	—		—		0.04
Basic and diluted income (loss) per share attributable to common shareholders of Evolent Health, Inc.	$	(0.44)	$	(3.94)	$	(3.67)

Anti-dilutive shares (in thousands) excluded from the calculation of weighted-average common shares presented above are presented below:


	For the Year Ended December 31,
	2021	2020	2019
Exchangeable Class B common stock	—	—	1,399
Restricted stock units ("RSUs"), performance-based RSUs and leveraged stock units ("LSUs")	1,807	797	813
Stock options	2,036	1,141	1,324
Convertible senior notes	12,602	11,206	10,361
Total	16,445	13,144	13,897